Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X:
“Check out our podcast on the importance of biomarker testing in the treatment of advanced NSCLC.
Collaborating with the one and only Dr. Fred Hirsch was a remarkable experience!”
Proceed to the podcast.
Source: Chul Kim/X